Publicaciones en colaboración con investigadores/as de University of Minnesota (11)

2022

  1. Assessment of Omecamtiv Mecarbil for the Treatment of Patients with Severe Heart Failure: A Post Hoc Analysis of Data from the GALACTIC-HF Randomized Clinical Trial

    JAMA Cardiology, Vol. 7, Núm. 1, pp. 26-34

2021

  1. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116

2020

  1. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials

    European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171

2019

  1. Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy

    EBioMedicine, Vol. 45, pp. 588-605

2016

  1. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II

    European Heart Journal, Vol. 37, Núm. 33, pp. 2591-2601

  2. Ultrasound-guided subcostal transversus abdominis plane blocks with liposomal bupivacaine vs. Non-liposomal bupivacaine for postoperative pain control after laparoscopic hand-assisted donor nephrectomy: A prospective randomised observer-blinded study

    Anaesthesia, Vol. 71, Núm. 8, pp. 930-937

2015

  1. Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study

    PLoS ONE, Vol. 10, Núm. 10

  2. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2012

  1. Concordance among pathologists in the second cardiac allograft rejection gene expression observational study (CARGO II)

    Transplantation, Vol. 94, Núm. 11, pp. 1172-1177

2008

  1. Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation

    Clinical Transplantation, Vol. 22, Núm. 6, pp. 809-814

2007

  1. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients

    Clinical Transplantation, Vol. 21, Núm. 1, pp. 18-23